Appendix C (Continued):
7. How are ecosystem value trends and Seed ‑ to ‑ Series ‑ A dynamics substantiated with public sources?
Public tables vary by year, so the diagnosis is corroborated using Dealroom’s 2025 ecosystem index and CVCA’s Q1 ‑ 2025 data showing seed/pre ‑ seed softness and fewer early ‑ stage deals. In brief: Dealroom and CVCA confirm current early ‑ stage gaps the package is designed to address.
8. Why is Estonia a relevant benchmark, and are its metrics precise?
Estonia’s 0% corporate tax on retained/reinvested profits is confirmed by official investment sources, while high VC/GDP and per ‑ capita metrics are documented in State of European Tech and national ecosystem reporting.
In brief: Estonia’s fiscal design and capital intensity offer a clear directional benchmark.
9. What does Israel’s Angels Law illustrate about investor ‑ side incentives?
Israel’s 2023–2026 incentives provide targeted investor tax credits and capital ‑ gains relief alongside Innovation Authority co ‑ investment, aligning with the crowd ‑ in logic for early ‑ stage risk capital. In brief: Targeted investor incentives plus co ‑ investment can reliably mobilize early ‑ stage capital.
10. Is the U.S. QSBS precedent current after 2025 updates?
Section 1202 continues to allow a 100% exclusion for qualifying gains up to the greater of US$10 million or 10× basis, with 2025 enhancements and the familiar ≥5 ‑ year hold for qualifying issuance, illustrating durable investor ‑ side design.
In brief: QSBS remains a flagship investor ‑ side incentive and was strengthened in 2025.
11. What do 2024–2025 VC intensity data indicate for Canada?
BDC shows Canada trailing leaders on VC/GDP, and Dealroom’s 2024 global wrap indicates depressed global VC and widening performance gaps, underscoring the need for coordinated crowd ‑ in at the early stage.
In brief: Independent data points to a widening gap that targeted crowd ‑ in tools can close.
60
Powered by FlippingBook